April 29, 2022

IronRock Insurance Company Limited (ROC), for the year ended December 31, 2021 posted gross premiums of $881.21 million relative $836.97 million; representing a 5% increase.

Change in gross provision for unearned premiums amounted to $43.11 million compared to $29.91 million in 2020. Resulting in gross insurance premiums revenue of $838.10 million (2020: $807.06 million). While, for the quarter, gross insurance premiums revenue closed at $710.35 million (2020: $65.46 million).

Written premiums ceded to reinsurers amounted to $686.76 million relative to $647.27 million in 2020, a 6% increase year over year and Reinsurers’ share of change in provision for unearned premiums amounted to $38.94 million (2020: $33.26 million). As a result, net insurance premium revenue amounted to $190.28 million (2020: $193.05 million). For the quarter, net insurance premium revenue totalled $48.07 million (2020: $48.42 million).

Claims expenses incurred closed the twelve months period at $189.60 million (2020: $262.05 million), while  Reinsurers’ share of claims and benefits incurred amounted to $98.53 million (2020: $172.49 million). As a result, net insurance claims totaled $91.07 million for the year ended December 31, 2021 (2020: $89.56 million).

Commission expenses incurred totaled $101.63 million in contrast to 2020’s $93.59 million, while commission earned grew by 16% from $148.70 million in 2020 to total $173.19 million for the year ended December 31, 2021.

ROC reported a profit before operating expenses of $170.76 million, 8% up from $158.60 million booked December 2020.

Operating expenses, for the year ended December 31, 2021, increased to $188.78 million relative to $186.07 million in the prior year. As such, underwriting loss over the year closed at $18.02 million versus a loss of $27.46 million in 2020. For the quarter, underwriting profit closed at $41.16 million (2020: $37.54 million).

Investment income increased from $40.21 million in 2020 to $43.87 million for 2021. Gain on sale of investment amounted to $9.85 million compared to $8.11 million in 2020. Foreign exchange gain amounted to 25.13 million compared to a FX gain of $11.82 million in 2020.

As a result, profit before taxation totaled $60.84 million compared to a profit before taxation of $32.83 million in 2020. In the quarter, profit before taxation amounted to $69.69 million (2020: $46.80 million).

Tax of $7.13 million was recorded (2020: Tax credit of $15.12 million), resulting in net profit for the period under review of $53.71 million (2020: $47.95 million). Net profit for the quarter closed at $62.56 million (2020: $61.92 million).

Total comprehensive income for the year totalled $52.54 million compared to $17.72 million booked twelve months earlier.

Earnings per share for the year totaled $0.25 (2020: EPS: $0.22). For the quarter, EPS amounted to $0.292 (2020: $0.289). The numbers of shares used in the calculations are 214,000,000 units. The stock price as at April 28, 2022 was $3.29 with a corresponding P/E of 13.11 times.

Balance Sheet Highlights:

As December 31, 2021, assets totaled $1.55 billion (2020: $1.40 billion) increasing by 11% year over year. This increase is mainly due to Investments that increased by $69.54 million to $634.85 million from $565.31 million. The increase also included ‘Reinsurance Assets’(increased by $45.79 million), ‘Short- term Investments’(increased by 50.53 million) and ‘Cash and cash equivalents’ (increased by $69.64 million). Tempered by ‘Securities purchased under resale’ that decreased by $79.49 million to $15.28 million.

Shareholder’s equity closed at $619.65 million (2020: $567.10 million). This resulted in a book value per share of $2.90 (2020: $2.65).

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer(s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view(s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.